InvestorsHub Logo
icon url

ohm20

05/21/20 8:37 AM

#79205 RE: hitekmastr #79203

I think you must be under a misapprehension. Leronlimab is a drug not a test. What the price will be for COVID-19 is unknown. If we sell at a discount of $1000 a dose then that 1 million doses becomes $1 billion. Another 3 million doses equals $4 billion.

But thanks for bringing it up so the profit potential could be explained properly.